Busulfan Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Busulfan Injection (injection) from Mylan Institutional, a Viatris Company with status To Be Discontinued. The shortage was first posted on 10/24/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Mylan Institutional, a Viatris Company
- Package NDC
- 67457-893-08
- Dosage Form
- Injection
- Presentation
- Busulfan, Injection, 6 mg/1 mL (NDC 67457-893-08)
- Initial Posting
- 10/24/2025
- Revised Date